Laboratory Industry Report
July 2009
LabCorp Plans to Acquire Monogram Biosciences for Approximately $155 Million
Looking to expand its molecular diagnostic portfolio, LabCorp (Burlington, N.C.) has agreed to acquire Monogram Biosciences (South San Francisco, Calif.), a manufacturer of pharmacogenomic tests or companion diagnostics. According to the merger agreement, LabCorp will acquire all outstanding shares of Monogram in a cash tender offer for $4.55 per share for an implied total equity value of approximately $106.7 million, or a total enterprise value of approximately $155 million, which includes net indebtedness. The deal is expected to close by the end of the third quarter.
Login | Subscribe
July 2009 - Table of Contents
Laboratory Industry Report is part of...
Focus Areas |
Product Group |
Washington G2 Medical Lab & Imaging Management |
Subscription Products |
